Status:
NOT_YET_RECRUITING
Amino Acid Infusion in Kidney Transplant Recipients
Lead Sponsor:
University Hospital, Martin
Conditions:
Short-term Graft Function
Metabolic Effects
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study addresses the impact of amino acid infusion in the early post-transplant period on graft function and the incidence of post-transplant complications.
Detailed Description
Background and Rationale: Delayed graft function (DGF) remains a significant challenge in kidney transplantation, particularly in recipients of deceased donor organs. DGF, often defined as the need fo...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years) undergoing deceased or living donor kidney transplantation
- First-time kidney transplant recipients
- No known allergy or contraindication to amino acids
- Stable hemodynamic status post-transplant
- Signed informed consent
Exclusion
- Patients requiring immediate dialysis post-transplant
- Multi-organ transplant recipients
- Severe hepatic dysfunction (Child-Pugh C)
- Uncontrolled infection or sepsis
- Malignancy within the past 5 years (except non-melanoma skin cancer)
- Prior participation in conflicting clinical trials
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06929637
Start Date
September 15 2025
End Date
January 1 2029
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Martin
Martin, Slovakia, Slovakia, 03601